Hormone Therapy

Breast care considerations for transgender and gender-diverse patients.

TL;DR

Breast care for transgender and gender-diverse persons requires consideration of unique histopathologic and anatomic changes induced by gender-affirming hormonal therapy and surgery, inclusive clinical environments, and tailored screening and risk assessment approaches.

Key Findings

Transgender and gender-diverse persons represent a small but growing population in the United States facing challenges in accessing inclusive, equitable, and evidence-based healthcare.

  • TGD persons seek gender-affirming care including gender-affirming hormonal therapy (GAHT) and gender-affirming surgery (GAS)
  • The literature specifically addressing breast care needs in TGD patients is described as 'scarce but growing'
  • Accessing inclusive, equitable, and evidence-based healthcare 'remains a challenge for this patient population'

Both GAHT and GAS induce clinically important histopathologic and anatomic changes in breast tissue of TGD persons.

  • These changes are described as 'clinically important histopathologic and anatomic changes in breast tissue'
  • The influence of GAHT and GAS on breast tissue is identified as a key topic requiring clinical review
  • These changes have made breast care 'an increasingly recognized topic of importance in gender-affirming care'

Establishing trusting patient-provider relationships is identified as a foundational component of breast care for TGD patients.

  • The paper reviews how to establish trusting patient-provider relationships as a distinct clinical consideration
  • Gender inclusivity in breast clinics and imaging centers is identified as a separate but related concern
  • These relational and structural factors are listed alongside clinical considerations such as screening and risk assessment

Breast cancer screening recommendations and barriers represent a distinct area of concern specific to TGD persons.

  • The paper reviews 'breast cancer screening recommendations and barriers' as a dedicated topic for TGD patients
  • Breast cancer risk and treatment considerations in TGD persons are reviewed separately from screening
  • The unique healthcare needs of TGD patients necessitate tailored approaches to screening that differ from cisgender patient protocols

Gender inclusivity in breast clinics and imaging centers is identified as a necessary structural consideration for TGD patient care.

  • Gender inclusivity in breast clinics and imaging centers is explicitly listed as a topic of review
  • This is framed as part of providing equitable care to TGD persons
  • The clinical environment is treated as a distinct factor alongside medical and surgical considerations

Have a question about this study?

Citation

Carroll E, Rogers C, Summerside M, Cortina C. (2024). Breast care considerations for transgender and gender-diverse patients.. Women's health (London, England). https://doi.org/10.1177/17455057241289706